• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    V

    Vassar Brothers Medical Center

    EST. 1887
    199论文总数
    663引用总数

    Vassar Brothers Medical Center (VBMC) (formerly Vassar Brothers Hospital) is a 350-bed not-for-profit hospital overlooking the Hudson River in Poughkeepsie, New York. It is part of the Nuvance Health healthcare network and is the major medical center in Dutchess County, New York.

    论文量&引用量时间轴

    机构学者

    论文(199)

    年份
    起
    –
    止
    排序
    1Nocturia is Associated with Biological Age Not Chronological Age
    Mohammad Hazique,Louis Salciccioli,Jeffrey P. Weiss,Karel Everaert,Tine DeBacker,Thomas F. Monaghan,Jason M. Lazar

    Nocturia, defined as waking at night to void during the main sleep period is among the most common and bothersome of lower urinary tract symptoms (LUTS). While widely viewed as an inevitable consequence of chronological aging, there is a considerable inter-individual variability as middle-aged adults may experience severe nocturia and older age individuals might not. Therefore, nocturia may be related to accelerated biological aging rather than simply “getting older”. Accordingly, we sought to compare associations of chronological and biological age with relation to nocturnal voiding frequency. In this pilot study, we prospectively studied 68 patients who were evaluated for cardiovascular disease - a condition in which chronological and biological age often differ considerably. Biological age was estimated using PhenoAge, a validated composite biomarker derived from 9 clinical and laboratory parameters reflecting systemic aging processes. Mean chronological age was significantly younger than mean biological age (70.5 ± 10.2 years vs. 78.8 ± 17.8 years, p < 0.001) and the two measures of age were significantly correlated (r=0.67, p<0.001). Median number of nighttime voids was 2. On univariate and mutlivariate analyses, ANV was significantly correlated with PhenoAge (r = 0.33, p=0.006), but not chronological age (r = 0.084, p = 0.49). In conclusion, this pilot study suggests that PhenoAge may better capture the physiological processes associated with nocturia than chronological age alone.

    2026Journal of Community Health(2026)
    引用
    AI阅读
    加入学术空间
    2Efficacy of Rituximab Plus Lenalidomide Regimens in Follicular Lymphoma: a Meta-Analysis of Randomized Controlled Trials
    Iftikhar Khan, Hira Habib, Ayesha Imran Butt,Ali Shan Hafeez, Moosa Mubarika,Ehsanullah Alokozay, Maheen Shaharyar, Sara Aleem, Umama Alam, Hooria Aiman Shadab, Amna binte Naeem, Muhammad Nouman,

    Follicular lymphoma (FL) is an incurable, indolent non-Hodgkin lymphoma with a high relapse rate despite effective chemoimmunotherapy. Lenalidomide, an immunomodulatory agent, in combination with rituximab (R²), has been evaluated as an alternative to chemoimmunotherapy and to other standard regimens in FL. We conducted a systematic review and meta-analysis to assess the efficacy and safety of R² compared with standard regimens in FL. A PRISMA-guided search of PubMed, Embase, and Cochrane Library through May 2025 identified randomized controlled trials (RCTs) comparing R² to rituximab monotherapy, chemoimmunotherapy, or lenalidomide alone. Four RCTs (n = 1315 patients) were included. Primary endpoints were overall response rate (ORR), complete response (CR) and partial response (PR). Secondary outcomes were 2-year progression-free survival (PFS), 3-year overall survival (OS) and adverse events. R² did not differ significantly from comparators in 2-year PFS in the primary analysis (RR = 1.53, 95

    2026Annals of Hematology(2026)
    引用
    AI阅读
    加入学术空间
    3Efficacy and Safety of Vadadustat Vs. Erythropoiesis-Stimulating Agents for Anemia of CKD: an Updated Systematic Review and Meta-Analysis Including Novel Dosing Regimens
    Kusuma Chowdary Pamulapati, Yashas Prasad Mylarappa, Mohmed Junaid H. Hingora, Venkata Vamsi Nagineni, Raam Mannam
    2026Journal of the American Society of Nephrology(2026)
    引用
    AI阅读
    加入学术空间
    4Novelty of Repeat Angiovac in Recurrent Tricuspid Valve Endocarditis
    C. Mitchell, J. Alexander, H. Ojeda-Martinez

    Abstract Background Infective endocarditis (IE) is an infection of the endocardial surface of the heart, most commonly affecting cardiac valves. Right-sided IE, particularly of the tricuspid valve, is notably prevalent among individuals with a history of intravenous drug use (IVDU). The standard of care consists of prolonged antibiotics and surgical intervention, including valve replacement. However, patients with active IVDU often have prohibitive operative risk or are not considered surgical candidates due to anticipated reinfection. Aspiration systems such as the AngioVac device have emerged as a bridge to surgical intervention and a debulking method appropriate for high-risk populations. Case Presentation A 48-year-old male with a history of IVDU on Suboxone and IE post-tricuspid valve excision (2016) and bioprosthetic tricuspid valve replacement (2023), presented to the hospital with complaints of persistent fever and altered mental status. Blood cultures grew MRSA. Transthoracic echocardiogram revealed a large vegetation on the bioprosthetic tricuspid valve. On day 3, the patient underwent AngioVac removal of the vegetation. Postoperatively, he developed acute hypoxic respiratory failure requiring intubation and bronchoscopy, which revealed MRSA, Enterobacter cloacae, and Prevotella species. His course was further complicated by persistent MRSA bacteremia, candidemia, septic emboli (pulmonary & intracranial), and ceftaroline-induced neutropenia. Despite targeted antimicrobial therapy to blood culture findings (daptomycin, ceftaroline, metronidazole, micafungin), repeat imaging demonstrated persistent and evolving tricuspid vegetations. Considering the patient was not an appropriate candidate for surgical intervention, the patient underwent a second AngioVac procedure on day 31 of hospitalization following extensive multi-disciplinary team meetings. Cultures were negative post-procedure. He gradually improved, was successfully decannulated following earlier tracheostomy, completed a course of 8 weeks of IV Vancomycin and 6 weeks of Micafungin. Patient was discharged on Doxycycline and Rifampin for long-term antibiotic suppression. Discussion This case demonstrates unique aspects of patient care, including the repeated use of AngioVac in managing persistent prosthetic tricuspid valve IE, and addresses a potential gap in current IE management strategies. While AngioVac is increasingly reported as an alternative to open surgery in high-risk IE patients, the literature is limited in describing its repeated utilization and benefit. Given this patient’s history, this case may highlight the benefit of AngioVac when surgical options are limited and palliative/debulking measures are desired to medically optimize the patient and their prognosis. Repeat AngioVac procedures may reduce the risk of further septic embolization and enable enough stabilization for appropriate multi-disciplinary medicine interventions and potentially further surgical evaluation. This abstract is funded by: None

    2026AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE(2026)
    引用
    AI阅读
    加入学术空间
    5Hypercapnic Respiratory Failure Secondary to Myxedema Coma: A Case Report
    Carrine S Kogulan, Oluwafemi Ajibola

    Hypothyroidism affects a large subset of the population, with many undiagnosed. In iodine-sufficient regions, chronic autoimmune thyroiditis (Hashimoto's) is the leading cause. Chronic, untreated hypothyroidism can result in multisystem complications, including cardiovascular disease, infertility, and respiratory failure. The most severe presentation, myxedema, is a medical emergency marked by altered mentation, ranging from lethargy to coma, hypothermia, and hypoventilation. Prompt recognition and treatment with thyroid hormone replacement are essential to improve outcomes. We present a case of hypercapnic respiratory failure secondary to myxedema coma. A 51-year-old female with morbid obesity (BMI 39.9 kg/m²) presented unresponsive, hypoxemic, and cyanotic, requiring emergent intubation. Labs revealed severe anemia (Hb 6.5 g/dL) and respiratory acidosis. The urinalysis was positive for infection, and the urine culture grew Escherichia (E.) coli. Imaging showed small pericardial and pleural effusions, and echocardiography revealed preserved ejection fraction (55%). Thyroid studies confirmed severe hypothyroidism with thyroid-stimulating hormone (TSH) 38.2 mIU/L and free thyroxine (T₄) < 0.07 ng/dL, consistent with myxedema coma. She was managed with IV levothyroxine, IV hydrocortisone, antibiotics, ventilatory support, diuresis, and electrolyte repletion. Following thyroid hormone therapy, her respiratory status and mentation improved, allowing extubation and discharge after 14 days on 2 L home oxygen. Myxedema coma-induced hypercapnic respiratory failure occurs through reduced central respiratory drive, respiratory muscle weakness, and impaired gas exchange from pleural effusions or pneumonia. Studies have shown diminished maximal inspiratory and expiratory pressures in hypothyroid patients, reversible with hormone replacement. Pericardial effusion, observed in up to one-third of severe hypothyroid cases, results from increased capillary permeability and typically resolves with levothyroxine therapy without invasive intervention. Hypercapnic respiratory failure secondary to myxedema coma is rare but life-threatening. Early diagnosis and thyroid hormone replacement are essential to prevent morbidity and mortality. Clinical vigilance is required for patients with unexplained respiratory failure, particularly women with nonspecific hypothyroid symptoms. Ensuring medication adherence, thyroid function monitoring, and adequate respiratory support is vital for preventing recurrence and improving outcomes.

    2026Cureus(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 199 篇论文

    合作机构(100)

    纽约州立大学合作论文 12
    密苏里大学合作论文 11
    Wyckoff Heights Medical Center合作论文 11
    Lake Erie College of Osteopathic Medicine合作论文 10
    Nuvance Health合作论文 9
    加利福尼亚州立大学洛杉矶分校合作论文 5
    布朗大学合作论文 5
    St. Luke''s Hospital合作论文 4
    Howard University Hospital合作论文 3
    匹兹堡大学医学中心合作论文 3

    机构统计